This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Joshua Brooks, PhD
Senior Director at Alnylam Pharmaceuticals
Speaker

Profile

Josh Brooks is a Senior Director in Process Sciences at Alnylam Pharmaceuticals, where he leads the Process Control and Innovation group. His team focuses on Stage 1 process validation and introducing new technologies into GMP manufacturing to enhance robustness and scalability. Josh received his Ph.D. in organic chemistry from the University of Rochester in 2012 under Alison Frontier, followed by postdoctoral training with Derek Tan at Memorial Sloan Kettering. He began his industry career in process chemistry at Ionis Pharmaceuticals before joining Alnylam in 2017.

Agenda Sessions

  • Enzymatic Ligation: A Next‑Generation Process for siRNA Manufacturing

    9:10am